Paul J. Hastings, Director at Pacira BioSciences, Inc. (PCRX), sold 7,000 shares at $41.85 ($293K) on 2023-05-15, disclosed to the SEC on 2023-05-17.
Scheduled sale ($293k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| NKTX | SELL | 2025-06-20 | $3K | — | Filing → |
| NKTX | SELL | 2025-01-17 | $38K | — | Filing → |
| NKTX | SELL | 2024-06-20 | $10K | — | Filing → |